Largest health care companies — Page 4
The 1,019 US-listed companies in the health care sector, ranked by market capitalisation. Sector comes from each company's Nasdaq classification; revenue and earnings come from its SEC filings.
Combined market cap
$9.815 T
10.5% of all US-listed value
Companies
1,019
Ranked #4 of 12 sectors
Average
$9.632 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 301 | Korsana BiosciencesKRSA | $1.38B | $30.30 | -0.85% | United States |
| 302 | Pennant GroupPNTG | $1.38B | $39.17 | -11.06% | United States |
| 303 | Cronos GroupCRON | $1.37B | $3.72 | +5.84% | Canada |
| 304 | InnovivaINVA | $1.37B | $19.22 | -9.62% | United States |
| 305 | Structure TherapeuticsGPCR | $1.35B | $19.00 | -6.68% | United States |
| 306 | Damora TherapeuticsDMRA | $1.35B | $21.87 | -4.66% | Denmark |
| 307 | Mineralys TherapeuticsMLYS | $1.35B | $15.28 | -10.12% | United States |
| 308 | AnaptysbioANAB | $1.35B | $45.63 | -3.96% | United States |
| 309 | Taysha Gene TherapiesTSHA | $1.35B | $4.14 | -5.16% | United States |
| 310 | Eton PharmaceuticalsETON | $1.35B | $47.12 | -7.10% | United States |
| 311 | Staar SurgicalSTAA | $1.34B | $26.63 | -1.99% | United States |
| 312 | KardiganKARD | $1.30B | $13.94 | -10.41% | United States |
| 313 | Opko HealthOPK | $1.30B | $1.76 | -0.85% | United States |
| 314 | Lumexa ImagingLMRI | $1.26B | $13.17 | +0.50% | United States |
| 315 | GH ResearchGHRS | $1.26B | $18.40 | -7.68% | Ireland |
| 316 | UroGen PharmaURGN | $1.26B | $25.72 | -10.53% | Israel |
| 317 | Tandem Diabetes CareTNDM | $1.25B | $17.91 | -5.98% | United States |
| 318 | Nektar TherapeuticsNKTR | $1.24B | $36.43 | -5.34% | United States |
| 319 | OmerosOMER | $1.24B | $17.11 | -5.89% | United States |
| 320 | InnovAgeINNV | $1.24B | $9.06 | -7.46% | United States |
| 321 | Lb PharmaceuticalsLBRX | $1.23B | $38.10 | -6.73% | United States |
| 322 | Silence TherapeuticsSLN | $1.23B | $19.74 | -0.33% | United Kingdom |
| 323 | Alpha Tau MedicalDRTS | $1.22B | $13.23 | -5.70% | Israel |
| 324 | ArtivionAORT | $1.22B | $25.02 | -5.41% | United States |
| 325 | AlphatecATEC | $1.22B | $7.84 | -5.37% | United States |
| 326 | MannkindMNKD | $1.21B | $3.78 | -3.94% | United States |
| 327 | Avalyn PharmaAVLN | $1.18B | $26.69 | -2.84% | United States |
| 328 | Inhibrx BiosciencesINBX | $1.18B | $80.00 | -7.79% | United States |
| 329 | Amphastar PharmaceuticalsAMPH | $1.18B | $27.65 | -1.34% | United States |
| 330 | PROCEPT BioRoboticsPRCT | $1.16B | $20.15 | -6.99% | United States |
| 331 | Omada HealthOMDA | $1.15B | $18.86 | -2.93% | United States |
| 332 | VerastemVSTM | $1.15B | $9.51 | -3.50% | United States |
| 333 | Vor BiopharmaVOR | $1.15B | $18.69 | -7.11% | United States |
| 334 | SpyGlass PharmaSGP | $1.14B | $34.17 | -0.81% | United States |
| 335 | FreenomeFRNM | $1.12B | $10.46 | -7.43% | United States |
| 336 | COMPASS PathwaysCMPS | $1.11B | $7.81 | -9.24% | United Kingdom |
| 337 | Integra LifesciencesIART | $1.10B | $14.13 | -4.66% | United States |
| 338 | Si-BoneSIBN | $1.09B | $24.26 | -2.77% | United States |
| 339 | IradimedIRMD | $1.09B | $85.36 | -3.64% | United States |
| 340 | Seaport TherapeuticsSPTX | $1.09B | $20.34 | -2.96% | United States |
| 341 | Castle BiosciencesCSTL | $1.05B | $34.25 | -4.21% | United States |
| 342 | AdaptHealthAHCO | $1.01B | $7.41 | +1.30% | United States |
| 343 | CeribellCBLL | $1.01B | $26.00 | -5.08% | United States |
| 344 | Janux TherapeuticsJANX | $985.5M | $16.12 | -11.33% | United States |
| 345 | HarrowHROW | $975.1M | $26.01 | -9.53% | United States |
| 346 | ImmaticsIMTX | $930.0M | $6.22 | -10.06% | Germany |
| 347 | MoonLake ImmunotherapeuticsMLTX | $919.6M | $10.81 | -6.53% | United States |
| 348 | Odyssey TherapeuticsODTX | $904.9M | $18.83 | -3.46% | United States |
| 349 | BioventusBVS | $898.2M | $10.66 | -6.65% | United States |
| 350 | SavaraSVRA | $896.8M | $4.37 | -6.33% | United States |
| 351 | Jade BiosciencesJBIO | $896.1M | $14.09 | -6.32% | United States |
| 352 | QuidelOrthoQDEL | $886.3M | $12.93 | -9.93% | United States |
| 353 | Pharming GroupPHAR | $884.9M | $12.53 | -1.88% | Netherlands |
| 354 | Oric PharmaceuticalsORIC | $883.1M | $8.52 | -8.78% | United States |
| 355 | Monte Rosa TherapeuticsGLUE | $872.8M | $10.23 | -5.45% | United States |
| 356 | Latigo BiotherapeuticsLTGO | $865.9M | $13.06 | -6.98% | United States |
| 357 | Alto NeuroscienceANRO | $861.0M | $21.94 | -5.84% | United States |
| 358 | InventivaIVA | $857.7M | $3.63 | -6.20% | France |
| 359 | City TherapeuticsCTY | $855.1M | $16.99 | +3.53% | United States |
| 360 | Rigel PharmaceuticalsRIGL | $848.1M | $45.40 | -11.48% | United States |
| 361 | OrthopediatricsKIDS | $843.4M | $32.30 | -3.61% | United States |
| 362 | Syndax PharmaceuticalsSNDX | $842.8M | $9.37 | -10.38% | United States |
| 363 | Beta BionicsBBNX | $840.5M | $15.46 | -8.79% | United States |
| 364 | Corvus PharmaceuticalsCRVS | $821.0M | $9.76 | -7.66% | United States |
| 365 | Aktis OncologyAKTS | $820.9M | $14.76 | -2.90% | United States |
| 366 | MeiraGTxMGTX | $818.2M | $8.52 | -9.57% | United States |
| 367 | Collegium PharmaceuticalCOLL | $816.5M | $25.08 | +5.96% | United States |
| 368 | CryoportCYRX | $813.4M | $16.06 | -3.83% | United States |
| 369 | Prime MedicinePRME | $806.2M | $4.45 | -10.56% | United States |
| 370 | InModeINMD | $769.4M | $13.39 | -5.74% | Israel |
| 371 | AlumisALMS | $756.5M | $5.85 | -10.76% | United States |
| 372 | AnnexonANNX | $755.5M | $3.99 | -7.97% | United States |
| 373 | ArdelyxARDX | $750.3M | $2.99 | -9.27% | United States |
| 374 | Lexicon PharmaceuticalsLXRX | $723.1M | $1.63 | +9.80% | United States |
| 375 | OmniAbOABI | $706.7M | $4.85 | -6.47% | United States |
| 376 | Cullinan TherapeuticsCGEM | $704.0M | $10.94 | -12.41% | United States |
| 377 | Sana BiotechnologySANA | $697.5M | $2.33 | -8.98% | United States |
| 378 | Starling OncologySTLN | $688.4M | $6.76 | -2.67% | United States |
| 379 | Solid BiosciencesSLDB | $686.4M | $6.15 | -5.67% | United States |
| 380 | Attovia TherapeuticsATTO | $684.1M | $14.99 | -3.94% | United States |
| 381 | Aura BiosciencesAURA | $659.6M | $6.36 | -4.36% | United States |
| 382 | Achieve Life SciencesACHV | $658.1M | $6.40 | -8.38% | United States |
| 383 | Ironwood PharmaceuticalsIRWD | $657.7M | $3.98 | +5.57% | United States |
| 384 | Ginkgo BioworksDNA | $646.9M | $10.06 | -13.69% | United States |
| 385 | Sagimet BiosciencesSGMT | $642.6M | $9.11 | -8.80% | United States |
| 386 | Wave Life SciencesWVE | $638.0M | $3.24 | -10.63% | Singapore |
| 387 | Bambusa TherapeuticsBBTX | $631.2M | $15.63 | -2.74% | United States |
| 388 | Zevra TherapeuticsZVRA | $626.6M | $10.53 | -5.73% | United States |
| 389 | Evotec SEEVO | $626.1M | $1.76 | +12.10% | Germany |
| 390 | Design TherapeuticsDSGN | $624.4M | $9.75 | -8.28% | United States |
| 391 | 4D Molecular TherapeuticsFDMT | $621.8M | $11.26 | -8.35% | United States |
| 392 | Obsidian TherapeuticsOBX | $620.2M | $10.04 | -8.64% | United States |
| 393 | Adlai Nortye GroupANL | $619.5M | $9.62 | +0.10% | Cayman Islands |
| 394 | Candel TherapeuticsCADL | $615.6M | $8.05 | -11.11% | United States |
| 395 | DBV TechnologiesDBVT | $614.9M | $9.78 | -1.61% | France |
| 396 | Helus PharmaHELP | $613.7M | $8.40 | -3.23% | Canada |
| 397 | GeronGERN | $612.0M | $0.95 | -12.04% | United States |
| 398 | Nuvectis PharmaNVCT | $610.7M | $17.76 | -3.84% | United States |
| 399 | Kura OncologyKURA | $606.3M | $6.82 | -10.45% | United States |
| 400 | ArriVent BioPharmaAVBP | $602.5M | $12.22 | -9.41% | United States |
Showing 301–400 of 1,019 companies. One row per company, with secondary share classes folded into their primary listing.
Industries in Health Care
Biotechnology: Pharmaceutical Preparations 498Biotechnology: Biological Products (No Diagnostic Substances) 163Medical Specialities 43Medical/Dental Instruments 124Medicinal Chemicals and Botanical Products 26Industrial Specialties 28Other Pharmaceuticals 10Hospital/Nursing Management 14Biotechnology: Electromedical & Electrotherapeutic Apparatus 26Biotechnology: Commercial Physical & Biological Resarch 12Biotechnology: In Vitro & In Vivo Diagnostic Substances 19Medical Electronics 4Ophthalmic Goods 8Medical/Nursing Services 29Misc Health and Biotechnology Services 10Precision Instruments 3Pharmaceuticals and Biotechnology 1Managed Health Care 1
Other sectors
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.